Literature DB >> 14977165

Estimation of Cmax and Tmax in populations after single and multiple drug administrations.

Laszlo Tothfalusi1, Laszlo Endrenyi.   

Abstract

Following the oral administration of drugs, the plasma concentration generally reaches, in principle, a single, well-defined peak (Cmax) at the time of Tmax. A complication for the direct estimation of Cmax and Tmax is that measurements of concentrations are recorded only at discrete time points. Theoretical equations characterizing the population distribution of Cmax and Tmax are derived in relationship to the pharmacokinetic model, its parameters, their variabilities, and experimental errors. These equations can be solved by numerical integration. The resulting means, variances and other summary statistics of Cmax and Tmax are evaluated under various conditions involving single and multiple drug administrations. Results gained by the proposed numerical method agree closely with results gained by Monte-Carlo simulations. It is argued that the numerical method could be useful to study the statistical properties of the investigated measures and could, in some cases, provide a viable alternative to simulations. It is demonstrated that Cmax is estimated directly with positive bias, especially following repeated drug administrations. As a consequence, the recorded peak-trough fluctuation (PTF), measured in the steady state, can be excessively large (even by orders of magnitude) particularly when drug accumulation is high. These results have practical implications for the development of drugs and drug formulations.

Mesh:

Substances:

Year:  2003        PMID: 14977165     DOI: 10.1023/b:jopa.0000008159.97748.09

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  27 in total

Review 1.  Statistical aspects of bioequivalence--a review.

Authors:  A W Pidgen
Journal:  Xenobiotica       Date:  1992-07       Impact factor: 1.908

2.  Presentation of results from bioequivalence studies.

Authors:  R Sauter; V W Steinijans; E Diletti; A Böhm; H U Schulz
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1992-07

3.  Truncated area under the curve as a measure of relative extent of bioavailability: evaluation using experimental data and Monte Carlo simulations.

Authors:  J Gaudreault; D Potvin; J Lavigne; R L Lalonde
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

4.  Absorption rate vs. exposure: which is more useful for bioequivalence testing?

Authors:  T N Tozer; F Y Bois; W W Hauck; M L Chen; R L Williams
Journal:  Pharm Res       Date:  1996-03       Impact factor: 4.200

Review 5.  Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling.

Authors:  B Meibohm; H Derendorf
Journal:  Int J Clin Pharmacol Ther       Date:  1997-10       Impact factor: 1.366

6.  Update on the statistical analysis of bioequivalence studies.

Authors:  V W Steinijans; D Hauschke
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1990-03

Review 7.  Use of statistical methods in evaluation of in vivo performance of dosage forms.

Authors:  W J Westlake
Journal:  J Pharm Sci       Date:  1973-10       Impact factor: 3.534

8.  Evaluation of different indirect measures of rate of drug absorption in comparative pharmacokinetic studies.

Authors:  L F Lacey; O N Keene; C Duquesnoy; A Bye
Journal:  J Pharm Sci       Date:  1994-02       Impact factor: 3.534

9.  Bioequivalence: performance of several measures of rate of absorption.

Authors:  F Y Bois; T N Tozer; W W Hauck; M L Chen; R Patnaik; R L Williams
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

10.  A pharmacokinetic drug-drug interaction study of venlafaxine and indinavir.

Authors:  G M Levin; L A Nelson; C L DeVane; S L Preston; G Eisele; S W Carson
Journal:  Psychopharmacol Bull       Date:  2001
View more
  4 in total

Review 1.  Evaluation of bioequivalence for highly variable drugs with scaled average bioequivalence.

Authors:  Laszlo Tothfalusi; Laszlo Endrenyi; Alfredo Garcia Arieta
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

Review 2.  Metrics for the evaluation of bioequivalence of modified-release formulations.

Authors:  Laszlo Endrenyi; Laszlo Tothfalusi
Journal:  AAPS J       Date:  2012-08-22       Impact factor: 4.009

3.  Increased motor impulsivity in a rat gambling task during chronic ropinirole treatment: potentiation by win-paired audiovisual cues.

Authors:  Melanie Tremblay; Michael M Barrus; Paul J Cocker; Christelle Baunez; Catharine A Winstanley
Journal:  Psychopharmacology (Berl)       Date:  2019-01-31       Impact factor: 4.530

4.  Interchangeability of two 500 mg amoxicillin capsules with one 1000 mg amoxicillin tablet after a single oral administration.

Authors:  A N Zaid; R Cortesi; J Kort; W Sweileh
Journal:  Indian J Pharm Sci       Date:  2010-07       Impact factor: 0.975

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.